"Thrombocytic" Natural Recordings by Native Speakers
Relating to platelets, especially those that cause thrombosis or the formation of blood clots.
Thrombo-angiitis is a medical term that refers to the inflammation of a blood vessel, often due to a combination of inflammation (angiitis) and a blood clot (thrombus). It is a rare condition that can occur in various forms, including thromboangiitis obliterans (Buerger's disease), which affects the arteries and veins in the arms and legs, particularly in smokers.
Thromboangiitis refers to the inflammation of blood vessels due to an abnormality of the blood or an unusual narrowing of the vessels.
Thromboclasis is a term that can refer to a phenomenon in the formation of blood clots. It refers to the piercing or disruption of a blood clot, often into the pulmonary artery during the process of a pulmonary embolism.
Pertaining to thrombosis (the formation of blood clots) or the breakdown or destruction of cells called thrombocytes (platelets).
A thrombocyte, also known as a platelet, is a small blood cell that plays a crucial role in the process of blood clotting. It is a type of cytoplasmic fragment or spherocyte found in the blood. Thrombocytes are produced in the megakaryocytes, a type of bone marrow cell, and are released into the circulation to help stop bleeding when a vessel is injured. They are attracted to the site of an injury, where they aggregate and form a platelet plug to facilitate clotting. Thrombocytes have no nucleus and are rich in various proteins that are essential for initiating blood coagulation, including adhesion, aggregation, and thrombin production. The normal range for this cell type in a healthy individual is approximately 150,000 to 450,000 thrombocytes per microliter of blood.
Platelets. A type of blood cell that helps to form blood clots and stop bleeding when a blood vessel is injured.
A rare blood disorder characterized by an excessive production of platelets (a type of blood cell that helps the blood to clot) in the bone marrow. People with thrombocytosis may be at an increased risk of blood clots and other bleeding complications.
Thrombocythemia is a medical condition characterized by an increased number of platelets in the blood, also known as thrombocytosis. It is a myeloproliferative neoplasm, a group of disorders in which the bone marrow produces too many cells. In thrombocythemia, the bone marrow produces too many platelets, which can lead to an increased risk of blood clots and other bleeding complications.<br><br>There are two main types of thrombocythemia:<br><br>1. Essential thrombocythemia (ET): a benign condition in which the bone marrow produces too many platelets, but it is not caused by another underlying disease.<br>2. Chronic myeloid leukemia (CML): a myeloproliferative neoplasm in which the bone marrow produces too many platelets, white blood cells, and red blood cells.<br><br>Symptoms of thrombocythemia may include:<br><br> Bruising or bleeding easily<br> Dizziness or lightheadedness<br> Shortness of breath<br> Headaches<br> Weakness<br> Pain in the abdomen or bones<br> Petechiae (small red spots on the skin)<br><br>Treatment for thrombocythemia usually involves controlling the platelet count with medications, and in some cases, surgery or radiation therapy may be necessary to remove abnormal bone marrow.
Thrombocytopaenia, also known as thrombocytopenia, is a condition characterized by an abnormally low level of platelets in the blood. Platelets are small blood cells that play a crucial role in blood clotting and stopping bleeding when a blood vessel is injured.
Thrombocytopaenic refers to a medical condition characterized by a low platelet count (thrombocytopenia).
Thrombocytopenic refers to a medical condition characterized by a low platelet count in the blood, often resulting in an increased risk of bleeding or bruising.
Thrombocytopoiesis refers to the process of forming and developing platelets, which are small blood cells that play a crucial role in blood clotting. It is a complex process that involves the production of platelets from hematopoietic stem cells in the bone marrow, through a series of maturation steps, before they are released into the bloodstream.